Literature DB >> 7966557

Evaluation of the genetic stability of the temperature-sensitive PB2 gene mutation of the influenza A/Ann Arbor/6/60 cold-adapted vaccine virus.

J Treanor1, M Perkins, R Battaglia, B R Murphy.   

Abstract

A single-gene reassortant bearing the PB2 gene of the A/Ann Arbor/6/60 cold-adapted virus in the background of the A/Korea/82 (H3N2) wild-type virus is a temperature-sensitive (ts) virus with an in vitro shutoff temperature of 38 degrees C. A single mutation at amino acid (aa) at 265 (Asp-Ser) of the PB2 protein is responsible for the ts phenotype. This ts single-gene PB2 reassortant virus was serially passaged at elevated temperatures in Madin-Darby canine kidney cells to generate ts+ phenotypic revertant viruses. Four ts+ phenotypically revertant viruses were derived independently, and each possessed a shutoff temperature for replication in vitro of > 40 degrees C. Each of the four phenotypically revertant viruses replicated efficiently in the upper and lower respiratory tracts of mice and hamsters, unlike the PB2 single-gene reassortant virus, confirming that the ts phenotype was responsible for the attenuation of this virus in rodents. Mating the ts+ revertants with wild-type virus yielded ts progeny in high frequency, indicating that the loss of ts phenotype was due to a suppressor mutation which was mapped to the PA gene in each of the four independently derived ts phenotypic revertants. Nucleotide sequence analysis confirmed the absence of new mutations on the PB2 gene and the presence of predicted amino acid changes in the PA proteins of the revertant viruses. These studies suggest that single amino acid changes at aa 245 (Glu-Lys) or 347 (Asp-Asn) of the PA protein can completely suppress the ts and attenuation phenotypes specified by the Asp-Ser mutation at aa 265 of the PB2 protein of the A/Ann Arbor/6/60 cold-adapted virus.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7966557      PMCID: PMC237228          DOI: 10.1128/JVI.68.12.7684-7688.1994

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  18 in total

1.  Molecular model of a eucaryotic transcription complex: functions and movements of influenza P proteins during capped RNA-primed transcription.

Authors:  J Braam; I Ulmanen; R M Krug
Journal:  Cell       Date:  1983-09       Impact factor: 41.582

2.  Extragenic suppression of temperature-sensitive mutations in RNA segment 8 by replacement of different rna segments with those of other influenza A virus prototype strains.

Authors:  C Scholtissek; S B Spring
Journal:  Virology       Date:  1982-04-15       Impact factor: 3.616

3.  Temperature-sensitive mutants of influenza A/Udorn/72 (H3N2) virus. I. Isolation of temperature-sensitive mutants some of which exhibit host-dependent temperature sensitivity.

Authors:  K Shimizu; M G Mullinix; R M Chanock; B R Murphy
Journal:  Virology       Date:  1982-02       Impact factor: 3.616

4.  Escape of a highly defective influenza A virus mutant from its temperature sensitive phenotype by extragenic suppression and other types of mutation.

Authors:  B R Murphy; M D Tolpin; J G Massicot; H Y Kim; R H Parrott; R M Chanock
Journal:  Ann N Y Acad Sci       Date:  1980       Impact factor: 5.691

5.  Genetic factors associated with loss of the temperature-sensitive phenotype of the influenza A/Alaska/77-ts-1A2 recombinant during growth in vivo.

Authors:  M D Tolpin; J G Massicot; M G Mullinix; H W Kim; R H Parrott; R M Chanock; B R Murphy
Journal:  Virology       Date:  1981-07-30       Impact factor: 3.616

6.  Temperature-sensitive mutants of influenza A virus. XI. Transfer of ts lesions in the Hong Kong/68-ts-1 [a] virus to the influenza A/Udorn/72 wild type.

Authors:  B R Murphy; E L Tierney; S B Spring; R M Chanock
Journal:  J Infect Dis       Date:  1976-12       Impact factor: 5.226

7.  Nucleoprotein and membrane protein genes are associated with restriction of replication of influenza A/Mallard/NY/78 virus and its reassortants in squirrel monkey respiratory tract.

Authors:  S F Tian; A J Buckler-White; W T London; L J Reck; R M Chanock; B R Murphy
Journal:  J Virol       Date:  1985-03       Impact factor: 5.103

8.  Rescue of an influenza A virus wild-type PB2 gene and a mutant derivative bearing a site-specific temperature-sensitive and attenuating mutation.

Authors:  E K Subbarao; Y Kawaoka; B R Murphy
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

9.  Extragenic suppression of a ts phenotype during recombination between ts mutants of two fowl plague virus strains with a ts mutation in gene 1.

Authors:  Y Ghendon; S Markushin; K Lisovskaya; C R Penn; B W Mahy
Journal:  J Gen Virol       Date:  1982-10       Impact factor: 3.891

10.  Production and level of genetic stability of an influenza A virus temperature-sensitive mutant containing two genes with ts mutations.

Authors:  B R Murphy; L J Markoff; N T Hosier; J G Massicot; R M Chanock
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441

View more
  21 in total

1.  Genotypic stability of cold-adapted influenza virus vaccine in an efficacy clinical trial.

Authors:  T A Cha; K Kao; J Zhao; P E Fast; P M Mendelman; A Arvin
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

2.  Codon substitution mutations at two positions in the L polymerase protein of human parainfluenza virus type 1 yield viruses with a spectrum of attenuation in vivo and increased phenotypic stability in vitro.

Authors:  Josephine M McAuliffe; Sonja R Surman; Jason T Newman; Jeffrey M Riggs; Peter L Collins; Brian R Murphy; Mario H Skiadopoulos
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

3.  Involvement of influenza virus PA subunit in assembly of functional RNA polymerase complexes.

Authors:  Atsushi Kawaguchi; Tadasuke Naito; Kyosuke Nagata
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

4.  Biochemical impact of the host adaptation-associated PB2 E627K mutation on the temperature-dependent RNA synthesis kinetics of influenza A virus polymerase complex.

Authors:  Shilpa Aggarwal; Stephen Dewhurst; Toru Takimoto; Baek Kim
Journal:  J Biol Chem       Date:  2011-08-04       Impact factor: 5.157

5.  Temperature-Sensitive Mutants in the Influenza A Virus RNA Polymerase: Alterations in the PA Linker Reduce Nuclear Targeting of the PB1-PA Dimer and Result in Viral Attenuation.

Authors:  Bruno Da Costa; Alix Sausset; Sandie Munier; Alexandre Ghounaris; Nadia Naffakh; Ronan Le Goffic; Bernard Delmas
Journal:  J Virol       Date:  2015-04-08       Impact factor: 5.103

6.  Engineering temperature sensitive live attenuated influenza vaccines from emerging viruses.

Authors:  Bin Zhou; Yan Li; Scott D Speer; Anju Subba; Xudong Lin; David E Wentworth
Journal:  Vaccine       Date:  2012-03-24       Impact factor: 3.641

7.  Influenza virus sequence feature variant type analysis: evidence of a role for NS1 in influenza virus host range restriction.

Authors:  Jyothi M Noronha; Mengya Liu; R Burke Squires; Brett E Pickett; Benjamin G Hale; Gillian M Air; Summer E Galloway; Toru Takimoto; Mirco Schmolke; Victoria Hunt; Edward Klem; Adolfo García-Sastre; Monnie McGee; Richard H Scheuermann
Journal:  J Virol       Date:  2012-03-07       Impact factor: 5.103

8.  Adaptive strategies of the influenza virus polymerase for replication in humans.

Authors:  Andrew Mehle; Jennifer A Doudna
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-07       Impact factor: 11.205

9.  Mutations in the PA Protein of Avian H5N1 Influenza Viruses Affect Polymerase Activity and Mouse Virulence.

Authors:  Gongxun Zhong; Mai Quynh Le; Tiago J S Lopes; Peter Halfmann; Masato Hatta; Shufang Fan; Gabriele Neumann; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2018-01-30       Impact factor: 5.103

10.  Reversion of Cold-Adapted Live Attenuated Influenza Vaccine into a Pathogenic Virus.

Authors:  Bin Zhou; Victoria A Meliopoulos; Wei Wang; Xudong Lin; Karla M Stucker; Rebecca A Halpin; Timothy B Stockwell; Stacey Schultz-Cherry; David E Wentworth
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.